Revenue Reaches 6.82 Billion Won, Net Profit 2.04 Billion Won in First Half

Expanding PNA Materials Business

Responding to Growth in Nucleic Acid Therapeutics Market

Accelerating AOC Development

HLB Panajin announced on August 14 that it recorded separate financial results of 6.82 billion won in revenue, 526 million won in operating profit, and 2.04 billion won in net profit for the first half of this year. Operating profit remained in the black, following 749 million won in 2024 and 736 million won in 2025.

HLB Panagen exterior. HLB Panagen

HLB Panagen exterior. HLB Panagen

View original image

The company explained that increased interest in and expanded supply of PNA (peptide nucleic acid) materials had a positive impact on its performance. As the development of therapeutics directly targeting genes and RNA expands in the global nucleic acid therapeutics market, the applications of PNA materials are also broadening.


HLB Panajin is increasing its supply of materials based on its proprietary PNA technology and production capabilities. Having recently secured new contracts, the company is also expanding collaborations with local companies and research institutes in the United States, seeking new global business opportunities. Its strategy is to foster the PNA materials business as a new growth axis while maintaining stable revenues from its existing molecular diagnostics and materials businesses.


The company will also ramp up development of antibody-oligonucleotide conjugates (AOC) utilizing PNA technology. AOC is a technology that selectively delivers oligonucleotides to specific tissues or cells by attaching them to antibodies. HLB Panajin plans to increase research and development applying its proprietary PNA technology, thereby enhancing commercialization potential.



Chief Executive Officer Jang Ingeun of HLB Panajin stated, "As the global nucleic acid therapeutics market grows, interest in PNA technology and business opportunities are expanding," adding, "We will strengthen domestic and international sales of our PNA materials business, explore new business opportunities, and accelerate AOC development to achieve more tangible results in the second half of the year."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing